Dietary Care for ADPKD Patients: Current Status and Future Directions

Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic nephropathy, and tolvaptan is the only therapy available. However, tolvaptan slows but does not stop disease progression, is marred by polyuria, and most patients worldwide lack access. This and recent preclinical resear...

Descripción completa

Detalles Bibliográficos
Autores principales: Carriazo, Sol, Perez-Gomez, Maria Vanessa, Cordido, Adrian, García-González, Miguel Angel, Sanz, Ana Belen, Ortiz, Alberto, Sanchez-Niño, Maria Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683072/
https://www.ncbi.nlm.nih.gov/pubmed/31336917
http://dx.doi.org/10.3390/nu11071576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683072/
https://www.ncbi.nlm.nih.gov/pubmed/31336917
http://dx.doi.org/10.3390/nu11071576

Ejemplares similares